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Introduction: Diabetes is an ambulatory care sensitive condition that can generally be managed in outpatient
settings with little or no need for inpatient care. As a preliminary step to investigate whether health disparities can
be detected in the inpatient setting in China, we study how diabetic patients hospitalized without prior primary
care contact or with greater severity of illness differ from other diabetic inpatients along socioeconomic and
clinical dimensions.
Methods: We conduct an observational study using three years of clinical data for more than 1,800 adult patients
with diabetes at two tertiary hospitals in East China. Univariate analysis and probit regression are used to
characterize the differences in socioeconomic and clinical factors between patients hospitalized for diabetes with
no prior primary care contact and those hospitalized with previous treatment experience. Secondarily, we use
ordinary least squares regression to estimate the socioeconomic and clinical differences associated with poor serum
glucose control at admission.
Results: We find that compared with patients hospitalized after prior treatment experience, inpatients with no
previous primary care contact for diabetes have worse clinical laboratory values, are more likely to be young and
male, to have lower education attainment, and to have poorer blood sugar control. Insurance, urban residence,
and previous use of diabetic medication are in turn negatively correlated with HbA1c levels upon admission.
Conclusion: Among hospitalized diabetic patients, socioeconomic factors such as lower education attainment,
rural residence and lack of full insurance are associated with avoidable hospitalizations or worse indicators of
health. Although we cannot definitively rule out selection bias, these findings are consistent with health
disparities observable even at the inpatient level. Future studies should study the underlying mechanism by
which traditionally vulnerable groups are more likely to be hospitalized for avoidable causes and with greater
severity of illness.
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In recent years, the burden of chronic illnesses has over-
taken that of infectious diseases globally [1]. China, the
world’s second largest economy that is home to nearly
20% of the global population [2], represents an important
country to study the burden, and in particular inequalities
in the burden of chronic illnesses such as diabetes. As in
India and Brazil, the prevalence of diabetes in China is
predicted to grow at a rate double that seen in the United
States [3,4]. A recent study estimates the annual economic
burden of diabetes in China at 17.6 billion Chinese Yuan
(CNY), or US$ 2.5 billion [5], a burden that can only be
expected to worsen as the number of people living with
diabetes rises.
Diabetes is currently the eighth leading cause of mortal-
ity worldwide [6], and contributes significantly to prema-
ture mortality in low and middle-income countries [7].
Yet it is also considered an ambulatory care sensitive con-
dition (ACSCs) that can often be effectively managed in a
primary care setting. Inpatient admissions for these condi-
tions are often classified as “preventable hospitalizations”
and are considered to be indicative of suboptimal primary
care [8]. Examining the factors associated with hospitaliza-
tions for ACSCs such as diabetes can help policymakers
identify vulnerable populations and formulate appropriate
measures to reduce the economic, physical, and emotional
burden of preventable hospitalizations.
There is a growing literature on health and socioeco-
nomic status in China [9,10] and around the world [11-13].
Studying the prevalence of diabetes in China, Chan et al.
[14] and Yang et al. [4] find that a low level of education is
a risk factor for diabetes. Yang et al. [4] also document an
association between pre-diabetes and education below the
college level. The relationship between insurance status and
access to primary care has also been investigated, docu-
menting an association between insurance and improved
access among socially disadvantaged groups such as the less
educated and the poor [15]. Nevertheless, we are not aware
of any previous study that documents a socioeconomic gra-
dient among diabetic inpatients in China.
Our primary objective is to investigate, among diabetic
inpatients in two Chinese tertiary care hospitals, how dia-
betic patients hospitalized without prior primary care con-
tact or with greater severity of illness differ from other
diabetic inpatients based on observable socioeconomic
and clinical characteristics. These differences may point to
underlying health disparities in China. First, we investigate
the associations between socioeconomic/clinical factors
and patient’s prior primary care treatment history for dia-
betes. We feel that hospitalization almost immediately
upon a diagnosis of diabetes (with no other previous con-
tact with the primary care system for the treatment of dia-
betes) is a particularly troubling first contact with the
healthcare system for treatment of an ACSC, which is amedical condition for which timely and appropriate ambu-
latory care should prevent the need for hospitalizations.
Under optimal conditions of access to primary care, DM
should ideally have been diagnosed and treated early in
the outpatient setting without the need for hospitalization
upon diagnosis. As articulated in the consensus statement
of the American Diabetes Association and the European
Association for the Study of Diabetes, “except in rare cir-
cumstances . . . hospitalization is not required for the initi-
ation or adjustment of therapy” [16].
Second, we investigate the socioeconomic factors that are
associated with hospitalizations characterized by poorer
control of serum glucose, as measured by HbA1c scores
(glycated hemoglobin, or blood sugar levels). Tight control
of blood sugar levels in diabetic patients is the primary goal
of timely and effective primary care and management, so
identifying patient groups with poor blood sugar control
may help policymakers direct scarce healthcare resources
to patients most vulnerable to this category of preventable
hospitalizations. Our two research questions together ask
whether there is evidence consistent with social gradients
existing even at the inpatient level, with traditionally vul-
nerable patient groups – such as those with low education
attainment, rural residence, or incomplete insurance
coverage – experiencing more avoidable hospitalizations
or greater severity of illness at admission.
Data and methods
Data
Our data set includes socioeconomic and clinical informa-
tion for all adult patients (aged 18 or older) hospitalized
with a primary diagnosis of type 2 Diabetes Mellitus (DM)
(all inpatients with an ICD 9 CM code of 250.x) (1) be-
tween May 1, 2005, and April 30, 2008, at Sir Run Run
Shaw Hospital, affiliated with the Zhejiang University
Medical School (hereafter SRRSH) (N = 960) and (2) all
adults admitted with type 2 DM between 2005 and 2008
at Shandong Provincial Hospital (SPH) located in Jinan,
Shandong Province (N = 911).
Both SRRSH and SPH are tertiary care hospitals catego-
rized as Class 3A level providers, the highest level of ac-
creditation for hospitals in China. Table 1 provides the
summary statistics of the characteristics of all patients
hospitalized for diabetes-related conditions between 2005
and 2008 at the respective hospitals. Because China has
never imposed gatekeeping requirements for access to
care at any of its hospitals, patients are free to self-refer to
providers of any accreditation level regardless of the sever-
ity of their illness. There is no theoretical catchment area
or predefined population from which SRRSH and SPH
draw their patients. In practice, however, these two urban
tertiary care hospitals serve a patient population defined
by their surrounding urban and rural areas. The primary
constraint is that health insurance programs generally
Table 1 Descriptive statistics
Reasons for inpatient admission Test of difference in mean†
All observations Newly diagnosed Treatment-experienced
Variable Mean Std dev Mean Std dev Mean Std dev Diff or ratio 95% CI
Panel A: Sir Run Run Shaw Hospital
(N = 960) (N = 134) (N = 849)
Patient age 55.60 12.89 49.91 12.18 56.52 12.78 −6.61 [−8.93 - -4.29]
Female 0.43 0.28 0.46 0.60 [0.45 - 0.80]
< High School 0.58 0.61 0.57 1.07 [0.92 - 1.24]
Insured 0.20 0.19 0.21 0.91 [0.62 - 1.32]
Semi-insured 0.44 0.42 0.44 0.95 [0.77 - 1.17]
Uninsured 0.36 0.40 0.35 1.12 [0.89 - 1.41]
Urban 0.44 0.44 0.45 0.99 [0.80 - 1.21]
County/town 0.18 0.15 0.18 0.83 [0.54 - 1.27]
Village 0.38 0.41 0.37 1.10 [0.88 - 1.37]
Married 0.97 0.97 0.97 1.00 [0.97 - 1.04]
Current smoker 0.26 0.34 0.24 1.41 [1.08 - 1.84]
Duration of DM (months) 67.30 64.42 4.69 9.69 77.47 63.78 −72.78 [−83.61 - -61.94]
BMI (kg/m2) 23.90 4.00 24.78 5.26 23.76 3.74 1.02 [0.27 - 1.77]
Fast. blood sugar (mg/dl) 163.95 66.28 186.60 70.91 160.30 64.90 26.30 [13.88 - 38.72]
Triglyceride mg/dl 201.88 209.51 242.83 265.11 195.37 198.67 47.46 [8.88 - 86.03]
Total cholesterol mg/dl 175.18 44.80 186.16 47.25 173.43 44.17 12.73 [4.50 - 20.96]
Plasma LDL-C mg/dl 103.59 39.81 109.19 33.72 102.72 40.62 6.47 [−1.00 - 13.95]
AST IU/L 27.79 26.05 37.66 48.13 26.21 20.02 11.45 [6.71 - 16.19]
ALT IU/L 30.52 30.51 40.87 36.31 28.86 29.16 12.01 [6.45 - 17.58]
Creatinine mg/dl 0.87 0.55 0.79 0.21 0.88 0.58 −0.10 [−0.20 - 0.003]
BUN mg/dl 15.87 7.77 14.55 5.15 16.08 8.10 −1.53 [−2.96 - -0.11]
eGFR ml/min/1.73 M2 101.39 34.54 111.05 31.22 99.84 34.81 11.22 [4.90 - 17.53]
HbA1c % 8.70 2.82 10.40 2.22 8.41 2.81 1.99 [1.48 - 2.50]
Complications upon diagnosis 0.32 0.41 0.30 1.35 [1.07 - 1.69]
Chronic complications 0.83 0.75 0.84 0.89 [0.80 - 0.98]
UKPDS CHD risk 24.63 0.69 18.77 1.39 25.59 20.97 −6.82 [−10.66 - -2.97]
UKPDS stroke risk 15.00 0.68 4.34 0.54 16.69 0.77 −12.35 [−16.16 - -8.55]
Drug expenditures 3,100.82 4,588.62 2336.80 2770.30 3231.51 4810.51 −894.71 [−1735.13 - -54.30]
Diagnostic test expenditures 2,106.74 1,131.80 1976.92 873.45 2132.77 1163.81 −155.85 [−362.73 - 51.02]
Surgical expenditures 96.57 456.74 57.44 287.07 103.12 478.82 −45.67 [−129.50 - 38.16]
Hospital room expenditures 693.40 1,039.34 622.01 931.19 706.59 1056.48 −84.58 [−275.30 - 106.14]
Therapy expenditures 309.89 1,625.24 176.82 359.85 332.10 1746.37 −155.28 [−453.59 - 143.04]
Medical material expenditures 596.51 2,297.50 344.97 386.96 638.50 2471.13 −293.53 [−715.04 - 127.98]
Total expenditures 6,903.93 8,328.53 5473.80 3956.79 7135.94 8815.95 −1,662.14 [−3181.44 - -142.84]
Panel B: Shandong Provincial Hospital
(N = 911) (N = 62) (N = 849)
Patient age 61.61 12.32 52.76 15.47 62.25 11.81 −9.49 [−12.62 - -6.37]
Female 0.50 0.44 0.50 0.88 [0.66 - 1.17]
< High School Variable not available for Shandong data
Insured 0.09 0.06 0.10 0.60 [0.22 - 1.64]
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Table 1 Descriptive statistics (Continued)
Semi-insured 0.69 0.44 0.71 0.62 [0.47 - 0.82]
Uninsured 0.21 0.50 0.19 2.63 [1.98 - 3.50]
Urban 0.88 0.71 0.89 0.80 [0.68 - 0.94]
Rural 0.12 0.29 0.11 2.64 [1.71 - 4.07]
Married 0.94 0.98 0.93 1.05 [1.01 - 1.10]
Current smoker 0.18 0.16 0.19 0.84 [0.47 - 1.51]
Duration of DM (months) 120.19 84.49 3.14 2.27 128.74 81.15 −125.60 [−145.83 - -105.36]
BMI (kg/m2) 25.30 3.98 25.47 4.66 25.29 3.92 0.18 [−0.93 - 1.30]
Fasting blood glucose (mg/dl) 157.28 44.21 159.69 38.80 157.10 44.60 2.59 [−7.52 - 12.70]
Plasma triglyceride mg/dl 155.04 133.11 166.06 158.28 154.22 131.13 11.84 [−28.53 - 52.21]
Plasma total cholesterol mg/dl 202.32 49.85 205.76 37.06 202.06 50.68 3.70 [−6.13 - 13.54]
Plasma LDL-C mg/dl 133.72 377.89 122.95 27.70 134.52 391.72 −11.57 [−38.81 - 15.67]
AST IU/L 23.79 26.50 30.09 39.57 23.33 25.26 6.76 [−3.24 - 16.76]
ALT IU/L 22.53 33.10 30.03 43.38 21.99 32.19 8.04 [−2.97 - 19.05]
Creatinine mg/dl 1.01 0.59 0.86 0.19 1.02 0.61 −0.16 [−0.22 - -0.10]
BUN mg/dl 17.44 12.29 14.41 5.81 17.67 12.62 −3.26 [−4.94 - -1.58]
eGFR ml/min/1.73 M2 Variable not available for Shandong Data
HbA1c % 10.05 2.58 11.03 2.93 9.98 2.54 1.05 [0.38 - 1.71]
Complication upon diagnosis Variable not available for Shandong data
Chronic complications 0.90 0.68 0.91 0.75 [0.63 - 0.89]
UKPDS CHD risk Variable not available for Shandong data
UKPDS stroke risk Variable not available for Shandong data
Drug expenditures 12,043.97 9,701.05 7,330.60 4,718.68 12,388.17 9,881.62 −5,057.57 [−7541.92 - -2573.21]
Diagnostic test expenditures 1,431.07 1,165.98 1,431.32 1,256.91 1,430.26 1,159.81 1.06 [−300.13 - 302.26]
Surgical expenditures 32.00 235.56 33.87 266.70 31.86 233.30 2.01 [−58.84 - 62.86]
Hospital room expenditures 935.89 1,642.43 574.35 356.56 962.29 1,695.71 −387.94 [−811.48 - 35.60]
Therapy expenditures 2,587.25 3,869.05 1,926.57 1,115.99 2,635.50 3,992.51 −708.93 [−1707.36 - 289.49]
Medical material expenditures Variable not available for Shandong data
Total expenditures 17,294.27 13,118.62 11,478.48 5,945.20 17,718.98 13,397.19 −6,240.50 [−9605.00 - -2876.00]
†Test of difference in means between the sample of patients hospitalized after diagnosis with no primary care (“newly diagnosed”), compared to patients with
hospitalized after having had primary care treatment for diabetes. T-test performed for continuous variables; prevalence ratios given for categorical variables.
Data: Inpatient admissions for Type 2 Diabetes Mellitus at (1) Sir Run Run Shaw Hospital (Hangzhou, China) (Panel A) and (2) Shandong Provincial Hospital
(Jinan, China), 2005–2008.
Observations of patients under 18 are excluded.
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locality hospitals, but patients willing to pay high out-of-
pocket expenses do travel from nearby provinces to seek
care at Class 3A hospitals such as SRRSH and SPH.
We exclude Type 1 Diabetes based on clinical manifesta-
tions and progression of the disease, poor islet B cell func-
tion, and the presence of Glutamic Acid Decarboxylase
autoantibody, insulin auto-antibody, or islet cell antibody.
From hospital administrative records, we also code whether
patients have health insurance or partial insurance.
Medical records indicate patient self-report of duration of
diagnosis. We refer to inpatients who report no previouscontact with the primary care system for the treatment of
DM as “newly diagnosed inpatients”. Inpatients with previ-
ous contact in the primary care setting are referred to as
“treatment-experienced inpatients”. The presence of com-
plications upon hospitalization is confirmed by medical
chart review of patients’ presenting symptoms and self-
report. Expenditure data associated with the hospitalization
are obtained from the claims data from the respective hos-
pital’s financial and accounting offices. To measure patient
severity at admission, we use patient vital signs and labora-
tory values for samples collected on the morning of the sec-
ond day of admission, including height, weight, body mass
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ney functions, as well as other commonly collected indi-
cators of diabetes progression such as neuropathy and
retinopathy.
Methods
To evaluate whether differences in the severity of illness
exist between newly diagnosed inpatients and treatment-
experienced inpatients, we report the means and, for
continuous variables, standard deviations (SD) of socio-
economic and clinical variables for these two subgroups.
Differences in means and their 95% confidence intervals
are calculated. We also present proportions for categor-
ical variables and their prevalence ratios, as well as the
95% confidence intervals around the ratios.
We conduct two separate multivariate regression analyses
to examine our dual research questions. To investigate the
differences in socioeconomic and clinical characteristics be-
tween newly diagnosed and treatment-experienced patients
controlling for multiple covariates, we use multivariate pro-
bit regression with the dependent variable equal to 1 if the
patient is newly diagnosed. Covariates in this multivariate
probit regression include dummies for the years 2006
through 2008, for the type of insurance (full or partial in-
surance), female gender, area of residence (urban, county),
employment and smoking status. HbA1c and patient age
are the two continuous variables included in the regression.
The omitted categorical variables are the year 2005, unin-
sured status, male gender, rural residence, full employment
and non-smoking status. A second specification for this
model replaces the continuous variable hba with a categor-
ical variable set to 1 if hba > = 10%. Because we do not have
random assignment into newly diagnosed and treatment-
experienced groups, our empirical specification is primarily
designed to characterize the differences between newly di-
agnosed and treatment-experienced patients conditional
upon a hospitalization.
For the second research question, we use ordinary least
squares regression to examine the correlations between
HbA1c scores and the various socioeconomic variables of
interest. We run two specifications of this regression: The
first includes all covariates as listed in the previous para-
graph (except HbA1c), and the second adds marital status,
prior medication history (dummies for the categories of
medication taken, i.e., oral medications or insulin), family
history of diabetes, existence of complications upon ad-
mission, and duration of diabetes diagnosis. We report
Huber-White heteroskedastic-robust standard errors.
The unbiasedness and efficiency of the probit and or-
dinary least squares models depends on the correct
model specifications, and in particular omitted variable bias.
We have included most of the traditional covariates in our
data to examine the relationship between measures of dia-
betes severity and socioeconomic and clinical factors, butcannot exclude the possibility that omitted variables may be
driving some of our findings. Because of limitations in the
SRRSH data, our sample excludes readmission patients. For
the SPH data, which include readmissions, we conduct ana-
lyses using not only new admissions but also the entire
sample of observations to investigate the sensitivity of our
results to different sample selection criteria.
This study has been approved by the Stanford Univer-
sity Institutional Review Board.Results
Descriptive statistics
In the SRRSH sample, the average age was 56 years; 57%
were male, 58% had less than a high school education, and
36% were uninsured. Patients in the SPH sample were
slightly older, with an average age of 62, equally divided
across genders, of which 21% were uninsured. We have no
data on educational attainment for the SPH sample
(Table 1).
In the SRRSH and SPH samples, respectively, 44% and
88% of patients were urban residents. Smokers accounted
for 26% and 18% of the sample at SRRSH and SPH,
respectively.
Descriptive statistics: newly diagnosed vs. treatment-
experienced inpatients
Descriptive statistics indicate that newly diagnosed pa-
tients in general have poorer clinical indicators of health
than treatment-experienced inpatients. The newly diag-
nosed patients at SRRSH had a higher body mass index
(BMI) (by 1.02 kg/m2, p < 0.01), higher fasting blood glu-
cose (by 26.3 mg/dl, p < 0.01), and higher mean HbA1c
(by 1.99 percentage points, p < 0.01). They also had
other indicators of poorer health: higher cholesterol (by
12.73 mg/dl, p < 0.01), triglycerides (by 47.46 mg/dl, p <
0.05), LDL (by 6.47 mg/dl, p < 0.05), aspartate amino-
transferase (AST) (by 11.45 IU/L, p < 0.01), and alanine
aminotransferase (ALT) (by 12.01 IU/L, p < 0.01), but
mixed indicators of renal function: creatinine (lower by
0.1 mg/dl, p < 0.1), blood urea nitrogen (BUN) (lower by
1.5 mg/dl, p < 0.1), and estimated glomerular filtration
rate (eGFR) (higher by 11.22 ml/min/1.73 M2, p < 0.01).
Relative to treatment-experienced patients, newly diag-
nosed SPH patients also had higher BMI, fasting blood
glucose, triglycerides, total cholesterol, and LDL, but these
differences failed to achieve statistical significance at con-
ventional levels. Newly diagnosed SPH patients did dem-
onstrate, however, higher AST (by 6.8 IU/L, p < 0.1) and
ALT (8.0 IU/L, p < 0.1).
Newly diagnosed patients were also more likely to re-
port that they had complications when first diagnosed
(e.g., 41% vs. 30% at SRRSH). At the time of discharge
from SRRSH, 75% of the newly diagnosed patients were
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The corresponding figure for SPH was 68%.
Overall, these statistics provide evidence that newly di-
agnosed patients are on average admitted for inpatient
care with clinically worse indicators of health than
treatment-experienced patients.
Because most of our regressions include multiple spec-
ifications, in the following section, we present the most
conservative (smallest) result.
Multivariate analysis: differences in socioeconomic
and clinical characteristics of newly diagnosed and
treatment-experienced patients
In Table 2, we report the conditional probabilities associ-
ated with various socioeconomic and clinical factors, given
an inpatient admission for Type 2 DM, of being a newly
diagnosed inpatient relative to a treatment-experienced in-
patient. Again, given data limitations, results from Table 2
are meant only to highlight the socioeconomic and clinical
differences between patients admitted virtually immedi-
ately upon diagnosis and patients who had preexisting
contact with the primary care system for the treatment
of diabetes. These results cannot predict prospectively
that a patient with a given socioeconomic or clinical
characteristic will become a newly diagnosed inpatient.
Moreover, results could possibly be driven by sample se-
lection given non-random assignment into the newly di-
agnosed and treatment-experienced groups, which we
discuss further below.
Returning to the discussion of our results, we show
that among patients admitted for hospitalization, multi-
variate probit regressions indicate that being younger,
being male (for the SRRSH sample only), having less
than a high school education (for the SRRSH sample
only), and having high HbA1c levels were positively cor-
related with hospitalization as a newly diagnosed patient
(Table 2) relative to treatment-experienced patients. In the
SRRSH sample, conditional on an inpatient admission,
each additional year in age is associated with a de-
crease in probability of 0.39% (p < 0.01, model (2)) for
newly diagnosed hospitalization. Relative to treatment-
experienced inpatients, newly diagnosed patients are
also 5.64% (p < 0.01, model (2)) less likely to be female;
and are 5.4% (p < 0.05, model (2)) more likely to be pa-
tients with less than a high school education. The asso-
ciation between lower educational attainment and
being hospitalized upon diagnosis is evident in the
SRRSH sample even when controlling for the higher
HbA1c of such patients.
With respect to the association between lower educa-
tion and newly diagnosed hospitalization, there is con-
cern that the association is driven entirely by selection
bias because of shorter survival rates associated with
lower socioeconomic status, causing patients with lowereducation to be under-represented among the non-
cases (treatment-experienced group). We address this
concern below.
First, we note that in our full SRRSH sample, univari-
ate analysis shows that patients with an education level
of high school or lower represents 61% of newly diag-
nosed patients, and 57% of the treatment-experienced
group. As indicated in Table 1, the null hypothesis of a
unit prevalence ratio for lower than high school attain-
ment between the two groups cannot be rejected.
Second, we restrict the data to patients admitted to
the hospital within five years of initial diabetes diagnosis
to reduce the difference in age of cases and non-cases,
with an average patient age of 41.21 years (SD 6.77) for
the newly diagnosed group, and 42.1 years (SD 5.56) for
the treatment-experienced group. With this specifica-
tion, the coefficient on the variable high school or less
remains positive and significant, or 8.65% (p < 0.01).
Third, we further restricted the sample to patients less
than fifty years of age and with a diabetes diagnosis of five
years or fewer. In this sample, the newly diagnosed group
had an average duration of diagnosis of 3.48 months (SD
7.32) and age of 42.21 years (SD 6.77) and the treatment-
experienced group had an average duration of diagnosis of
25.45 months (SD 20.51) and age of 42.10 years (SD 5.56).
In this probit regression, the coefficient on “high school or
less” is 18.77% (p < 0.01).
Finally, we used the full sample and employed a nearest
neighbor matching strategy, choosing the three observa-
tions from the non-cases (treatment-experienced patients)
that are the closest match in gender, age, HbA1c scores,
insurance status, residence type, and year of admission to
each newly diagnosed inpatient. This specification also
yields a statistically significant positive association (5.9%,
p < 0.05) between lower education attainment and being a
newly diagnosed inpatient. This estimate from the nearest
neighbor matching method is remarkably close to the re-
sult from the OLS specification (5.4%, p < 0.05).
We now return to the results in Table 2. Among pa-
tients hospitalized for DM, each additional percentage
point in HbA1c score is associated with a 1.95% (p < 0.01,
model (1)) increase in the probability of a newly diagnosis
hospitalization; and newly diagnosed inpatients are 21.4%
(p < 0.01, model (2)) more likely to have an HbA1c score
of 10% or more than treatment-experienced inpatients.
Turning to the results from the SPH data, we find again
that among DM inpatients, each additional year of age
is associated with a 0.26% (p < 0.01, models (3, 4)) decrease
in the probability of newly diagnosed hospitalization.
On the other hand, every percentage point increase in
HbA1c score is positively associated (by 0.6%, p < 0.05,
model (3)) with the likelihood of being a newly diagnosed
rather than a treatment-experienced inpatient. Moreover,
having HbA1c of greater than 10% is positively associated
Table 2 Differences in socioeconomic and clinical characteristics between newly diagnosed and treatment-experienced
diabetic inpatients
Sir Run Run Shaw Hospital Shandong Provincial Hospital
New admissions only† All observations New admissions only†
(1) (2) (3) (4) (5) (6)
Dependent variable: first diagnosis of T2D within 6 months of inpatient admission (=1 if yes)
Patient age −0.46 −0.39 −0.26 −0.26 −0.28 −0.28
[−0.64 - −0.28)] [−0.57 - −0.21] [−0.38 - −0.14] [−0.38 - −0.14] [−0.42 - −0.15] [−0.41 - −0.15]
Female −6.37 −5.64 −2.54 −2.44 −2.66 −2.56
[−11.2 - −1.52] [−10.4 - −0.86] [−6.23 - 1.15] [−6.13 - 1.25] [−6.80 - 1.48] [−6.70 - 1.58]
< High school 6.02 5.41 Not available Not available Not available Not available
[1.59 - 10.4)] [1.05 - 9.77]
Insurance status
Insured 1.99 2.53 −2.03 −2.15 −1.51 −1.52
[−4.98 - 8.95] [−4.51 - 9.58] [−7.11 - 3.05] [−7.15 - 2.85] [−8.06 - 5.04] [−8.07 - 5.03]
Semi-insured −0.038 0.8 −6.80 −6.77 −7.00 −6.94
[−4.89 - 4.82] [−3.99 - 5.60] [−12.8 - −0.84] [−12.7 - −0.792] [−13.4 - −0.61] [−13.3 - −0.53]
Residence
Urban 2.35 2.64 −0.578 −0.66 −0.97 −1.07
[−3.00 - 7.71] [−2.64 - 7.93] [−5.75 - 4.60] [−6.07 - 4.75] [−6.93 - 4.99] [−7.09 - 4.95]
County/town −2.29 −0.71 Not available Not available Not available Not available
[−8.08 - 3.51] [−6.74 - 5.31]
Smoking history −0.76 −0.46 −1.84 −1.73 −2.14 −2.02
[−5.84 - 4.32] [−5.50 - 4.59] [−5.31 - 1.63] [−5.24 - 1.78] [−6.08 - 1.80] [−6.00 - 1.96]
Serum glucose
HbA1c % 1.95 0.56 0.60
[1.35 - 2.56] [0.01 - 1.12] [−0.024 - 1.23]
HbA1c% > 10% 21.4 3.07 3.40
[15.1 - 27.7] [−0.144 - 6.28] [−0.21 - 7.01]
Year fixed effects Included Included Included Included Included Included
Observations 900 900 822 822 741 741
All coefficients reported in % terms (decimal shifted two places to the right) to increase legibility.
95% confidence interval reported for marginal effects.
Year fixed effects are dummy variables for the years 2006, 2007, and 2008.
†“New admissions only” means that only the first inpatient observation of each unique patient ID is Included the sample. Data: Inpatient admission for T2D, Sir Run
Run Shaw Hospital (Hangzhou, China) and Shandong Provincial Hospital from 2005 to 2008. Patients under 18 are excluded. Econometric model: Probit regression with
dependent variable equal to 1 if patient admitted within 6 months of first diagnosis of T2D and 0 if admitted with a duration of diagnosis greater than 6 months.
Categorical independent variables are italicized, so dy/dx represents the discrete change of dummy variables from 0 to 1.
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model (4)). We had no data on patient educational attain-
ment in the SPH sample.
Association between HbA1c scores at admission and
socioeconomic/clinical characteristics
In Table 3, the most consistent finding across samples is
that patients with full insurance are less likely to be admit-
ted for poorer serum glucose control among DM inpa-
tients. In the SRRSH sample, fully insured patients have
HbA1c scores that are 0.58 (p < 0.01, model (1)) lower. This
correlation is also evident in the SPH data: insured patientshave HbA1c percentages that are 1.62 (p < 0.01, model (4))
lower. The single socioeconomic factor that is associated
with being admitted with lower levels of HbA1c is urban
residence. In the SRRSH sample, we find that urban resi-
dents are admitted with HbA1c scores that are lower by 0.4
(p < 0.05, model (1)) percentage points. In addition, also in
the more detailed SRRSH sample, prior medication history,
which is itself likely to be highly correlated with past treat-
ment experience in the primary care setting, is associated
with lower HbA1c scores upon admission, by 1.26 (p <
0.01, model (2)) for patients on oral medication, and by
1.37 (p < 0.01, model (2)) for patients on insulin therapy.
Table 3 Factors associated with poor serum glucose control at time of hospital admission
Sir Run Run Shaw Hospital Shandong Provincial Hospital
New admissions only† New admissions only† All admissions
VARIABLES (1) (2) (3) (4) (5) (6)
Dependent variable: HbA1c
Demographic
Patient age −0.021 −0.019 −0.008 −0.0094 −0.011 −0.014
[−0.034 - −0.0073] [−0.033 - −0.0061] [−0.024 - 0.0078] [−0.026 - 0.0072] [−0.026 - 0.0045] [−0.03 - 0.002]
Married Not included 0.23 Not included −0.33 Not included −0.49
[−1.91 - −0.82]
[−0.49 - 0.95] [−1.1 - 0.44] [−1.19 - 0.22]
Female −0.37 −0.28 0.21 0.19 0.16 0.13
[−0.74 - 0.012] [−0.66 - 0.095] [−0.21 - 0.63] [−0.23 - 0.62] [−0.20 - 0.53] [−0.24 - 0.50]
Urban −0.37 −0.4 −0.47 −0.47 −0.39 −0.38
[−0.73 - −0.018] [−0.74 - −0.053] [−1.23 - 0.30] [−1.23 - 0.30] [−1.14 - 0.35] [−1.13 - 0.36]
County/town −0.13 −0.082 Not available Not available Not available Not available
[−0.86 - 0.61] [−0.83 - 0.67]
< High school −0.085 −0.14 Not available Not available Not available Not available
[−0.55 - 0.38] [−0.59 - 0.32]
Unemployed −0.32 −0.28 0.011 0.014 0.063 0.064
[−0.91 - 0.27] [−0.86 - 0.30] [−0.82 - 0.84] [−0.82 - 0.85] [−0.74 - 0.87] [−0.74 - 0.87]
Past treatment
Oral agents Not included −1.26 Not available Not available Not available Not available
[−1.71 - −0.81]
Insulin Not included −1.37 Not available Not available Not available Not available
[−0.49 - 0.95] [−1.1 - 0.44] [−1.19 - 0.22]
Insurance
Insured −0.58 −0.59 −1.62 −1.62 −1.74 −1.74
[−1.02 - −0.15] [−1.01 - −0.17] [−2.62 - −0.62] [−2.62 - −0.62] [−2.68 - −0.80] [−2.68 - −0.80]
Semi-insured −0.053 −0.0018 −0.41 −0.41 −0.45 −0.44
[−0.42 - 0.31] [−0.37 - 0.36] [−1.20 - 0.37] [−1.20 - 0.37] [−1.21 - 0.32] [−1.20 - 0.32]
Clinical
Smoker −0.083 −0.031 0.24 0.23 0.21 0.19
[−0.44 - 0.29] [−0.39 - 0.33] [−0.22 - 0.69] [−0.22 - 0.69] [−0.26 - 0.68] [−0.28 - 0.66]
Duration/months 0.0015 0.0039 −0.0017 −0.0017 −0.0016 −0.0015
[−0.0072 - 0.010] [−0.0048 - 0.013] [−0.0041 - 0.00067] [−0.0042 - 0.00070] [−0.0038 - 0.00056] [−0.0037 - 0.00069]
Family history Not included −0.33 Not included −0.0036 Not included −0.10
[−0.74 - 0.078] [−0.38 - 0.37] [−0.45 - 0.24]
Year fixed effects Included Included Included Included Included Included
Observations 899 898 808 808 910 910
R-squared 0.04 0.08 0.05 0.05 0.06 0.06
95% confidence intervals in brackets. Coefficients are reported to two significant digits. Ordinary Least Squares Regression.
†“New admissions only” means that only the first inpatient observation of each unique patient ID is included the sample.
Data: Inpatient admission for T2D, Sir Run Run Shaw Hospital (Hangzhou, China) and Shandong Provincial Hospital (Jinan, China) from 2005 to 2008. Patients
under 18 are excluded.
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We find that diabetic patients hospitalized without prior
primary care treatment experience or with poorer serum
control differ from other diabetic inpatients along socio-
economic and clinical lines, and are more likely to be
from traditionally vulnerable groups such as those with
lower education attainment, without full insurance, or
with rural residence. A significant minority of inpatients
in our samples is hospitalized shortly after diagnosis,
with no other treatment history for diabetes in the pri-
mary care setting. Our univariate analyses show that
compared to treatment-experienced inpatients, newly di-
agnosed inpatients have worse indicators of health upon
admission. Furthermore, our multivariate probit analysis,
conditional on a diabetic inpatient admission, indicates
that newly diagnosed patients tend to have low educa-
tional attainment in the SRRSH sample, even when con-
trolling for HbA1c scores at admission. Second, high
HbA1c levels are in turn negatively associated with full
insurance status and, in the SRRSH sample, also nega-
tively correlated with urban residence and preexisting
access to oral medications and/or insulin.
These associations must be interpreted within the con-
text of the available data for analysis. On the one hand,
our finding of a socioeconomic and clinical gradient in
avoidable hospitalizations is consistent with growing but
sparse literature on health disparities in China among dia-
betic patients. Previous literature identified that lower
education attainment is a risk factor for both pre-diabetes
and diabetes in China [4,14], and our research provides
preliminary evidence that these disparities may well ex-
tend into the inpatient setting, where the less educated
are more likely to be admitted for hospitalizations with
no prior primary care contact for the treatment of dia-
betes. On the other hand, our results may be driven by
non-random assignment into the newly diagnosed and
treatment-experienced groups. In particular, the associ-
ation between lower education attainment and new
diagnosis hospitalizations may be due to precocious
deaths and underrepresentation of such patients in the
treatment-experienced group. When we match the
newly diagnosed and treatment experienced group on
age and other observable covariates or restrict our ana-
lyses to younger patients (for whom precocious death is
less of a concern), however, the association between
lower education and arguably avoidable new diagnosis
hospitalization remains.
Our study may also be the first to investigate the cor-
relations between socioeconomic factors and poorer
control of serum glucose levels (high HbA1c scores) at
inpatient admission. We find that among patients hospi-
talized at tertiary hospitals in Eastern China, lack of or
incomplete insurance coverage, and in the SRRSH sam-
ple, rural residence and drug therapy-naïve status, arecorrelated with higher HbA1c percentages. Taken to-
gether, our investigation of the two research questions
demonstrates that lower educational attainment, rural
residence, and/or lack of full insurance are associated
with new diagnosis hospitalizations or greater severity of
illness at admission for diabetic inpatients at two tertiary
care centers in two coastal Chinese provinces. These
findings point to potential signs of inequity in access to
health care, and/or disparities in health behavior, liter-
acy, and survival between patients of disparate socioeco-
nomic status in China.
The association between lack of full insurance and
hospitalization for diabetes in our study is consistent
with the findings of a vast literature showing that finan-
cial constraints may delay needed medical care [17-20].
Individuals with less education may lack knowledge of
diabetes and the roles of lifestyle, screening, symptoms,
and good control in the course of the disease, as well as
face more daunting access barriers to early and effective
treatment. Although our study is observational in nature
and limited to only two hospitals, it is consistent with a
finding of socioeconomic gradients in health and in
healthcare utilization. Such gradients may partly be re-
lated to health behaviors; better-educated Chinese even
in rural areas are less likely to smoke, drink, or have a
chronic disease [21]. Relative to the existing literature
that focuses on diabetes prevalence or barriers to pri-
mary care, our study shows that such inequities may well
be observable even at the inpatient level.Limitations
The principal limitation of our study is the lack of informa-
tion on the hospitalization rates of diabetic patients treated
as outpatients. As such, our results can best be interpreted
as the likelihood of having certain socioeconomic and clin-
ical factors conditional on inpatient admission for DM.
Further, as noted previously, our finding of an association
between lower education and new-diagnosis hospitaliza-
tions may have been driven by differential survival of such
patients in our full sample. However, the association re-
mains (and increases both in magnitude and precision)
even when matching newly diagnosed and treatment-
experienced patients on age, suggesting that sample selec-
tion is unlikely the sole reason for the education gradient
found in our sample.
We also note the potential for recall bias in key vari-
ables in the study, including duration of diagnosis and
complications at admission. However, due to the saliency
of an inpatient admission soon after the first diagnosis
of diabetes, it is unlikely that such a recall bias would be
extensive. Moreover, complications present upon admis-
sion are recorded in medical charts and unlikely to be
substantially affected by recall bias.
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uncover the underlying mechanism that links populations
with lower socioeconomic status with a new-diagnosis
hospitalizations or poorer serum glucose control. Financial
constraints, lack of knowledge, preferences for large urban
tertiary care institutions, or even spurious associations
driven by sample selection would certainly require differ-
ent policy responses to tackle the growing prevalence of
chronic illnesses in China.
Conclusion
Our findings of an association between greater severity
of illness or hospitalizations upon first diagnosis and vul-
nerable groups such as individuals with lower education
attainment, rural residence, and/or less than full insur-
ance in two tertiary care hospitals are consistent with
health disparities among diabetic patients in China.
These inequalities may arise for a variety of reasons, in-
cluding lack of access to primary care, health illiteracy,
shorter survival, or other unobserved heterogeneity and
selection in our study sample. Nevertheless, they point
to a disturbing inequality in a country with an escalating
diabetes prevalence rate. If these findings are driven by
lack of access by vulnerable groups, China’s recent ex-
pansions of basic health insurance and investments in
community health services represent an encouraging
trend that may help to alleviate these disparities [22]. A
salient goal of China’s recent health reforms is to in-
crease use of primary care and decrease crowding at ter-
tiary hospitals. An important marker of progress will be
the extent to which primary care can prevent, detect,
and control chronic diseases such as diabetes. As China
continues on its health reform, future research should
investigate whether these findings can be generalized to
a larger population of Chinese diabetic inpatients, and
whether the underlying cause of our observed dispar-
ities is driven by inequitable access to primary care
along the urban/rural, insurance status, and education
attainment divide.
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